The Italian Network for Tumor Biotherapy (NIBIT): getting together to push the field forward.
Maio M, Nicolay HJ, Ascierto P, Belardelli F, Camerini R, Colombo MP, Queirolo P, Ridolfi R, Russo V, Anzalone L, Fonsatti E, Parmiani G.J Transl Med.
2008 Feb 12;6:8. doi: 10.1186/1479-5876-6-8.PMID: 18269750 Free PMC article.
As for a consolidated tradition, the 5th annual meeting of the Italian Network for Cancer Biotherapy took place in the Certosa of Pontignano,
a Tuscan monastery, on September 20-22, 2007. The congress gathered more than 40 Italian leading groups representing academia, biotechnology
and pharmaceutical industry. Aim of the meeting was to share new advances in cancer bio-immunotherapy and to promote their swift translation
from pre-clinical research to clinical applications. Several topics were covered including: a) molecular and cellular mechanisms of tumor
escape; b) therapeutic antibodies and recombinant constructs; c) clinical trials up-date and new programs; d) National Cooperative Networks
and their potential interactions; e) old and new times in cancer immunology, an "amarcord". Here, we report the main issues discussed during the meeting.